摘要
目的:为抗肿瘤药的合理使用提供参考。方法:对重庆地区34家医院2011-2013年抗肿瘤药的销售金额、用药频度(DDDs)、日均费用等进行回顾性分析。结果:抗肿瘤药的销售金额2012年较2011年增长23.74%,2013年较2012年增长36.89%。DDDs除烷化剂抗肿瘤药连续3年略有下降外,其余均呈逐年上升趋势。中成药的DDDs和销售金额连续3年列第1位。结论:重庆地区医院抗肿瘤药应用现状基本符合我国当前的药品总体消耗趋势,不良反应少、价格低廉的中成药占据了重庆地区抗肿瘤药的较大市场。
OBJECTIVE：To provide reference for rational use of antineoplastic agents. METHODS：The utilization of antineoplastic agents in 34 hospitals from Chongqing area during 2011-2013 was analyzed retrospectively in terms of consumption sum,DDDs and DDC,etc. RESULTS：The consumption sum of antineoplastic agents increased by 23.74% in 2012 compared with 2011,and increased by 36.89% in 2013 compared with 2012. DDDs of antineoplastic agents increased year by year except that of botanic antineoplastic agents decreased slightly in 3 years. The DDDs of Chinese patent medicines remained at the first place over the three years;the consumption sum of it took up the first place over the three years too. CONCLUSIONS：The consumption of antineoplastic agents in Chongqing is in line with the general tendency of drug consumption in China. Chinese patent medicines which have little side effect and low price occupy an important place among all antineoplastic agents in Chongqing area.
出处
《中国药房》
CAS
北大核心
2015年第29期4048-4051,共4页
China Pharmacy
关键词
抗肿瘤药
销售金额
用药频度
用药分析
Antineoplastic agents
Consumption sum
DDDs
Analysis of drug use
